These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9257533)

  • 41. Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes.
    Medina MF; Joshi S
    Nucleic Acids Res; 1999 Apr; 27(7):1698-708. PubMed ID: 10076002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospects for antiviral ribozymes and deoxyribozymes.
    Peracchi A
    Rev Med Virol; 2004; 14(1):47-64. PubMed ID: 14716691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of preformed hammerhead ribozymes in the gene therapy of cancer (review).
    Sioud M
    Int J Mol Med; 1999 Apr; 3(4):381-4. PubMed ID: 10085409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
    Cancer Gene Ther; 1995 Dec; 2(4):263-71. PubMed ID: 8548580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and preparation of a multimeric self-cleaving hammerhead ribozyme.
    Ruiz J; Wu CH; Ito Y; Wu GY
    Biotechniques; 1997 Feb; 22(2):338-45. PubMed ID: 9043708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potential application of ribozymes for the treatment of hematological disorders.
    James HA
    J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
    Pachuk CJ; Yoon K; Moelling K; Coney LR
    Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient RNA ligation by reverse-joined hairpin ribozymes and engineering of twin ribozymes consisting of conventional and reverse-joined hairpin ribozyme units.
    Ivanov SA; Vauléon S; Müller S
    FEBS J; 2005 Sep; 272(17):4464-74. PubMed ID: 16128815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assaying synthetic ribozymes in plants: high-level expression of a functional hammerhead structure fails to inhibit target gene activity in transiently transformed protoplasts.
    Mazzolini L; Axelos M; Lescure N; Yot P
    Plant Mol Biol; 1992 Nov; 20(4):715-31. PubMed ID: 1450386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A method for generating transcripts with defined 5' and 3' termini by autolytic processing.
    Altschuler M; Tritz R; Hampel A
    Gene; 1992 Dec; 122(1):85-90. PubMed ID: 1452041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engineering of RNase P ribozyme for gene-targeting applications.
    Raj SM; Liu F
    Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The many faces of the hairpin ribozyme: structural and functional variants of a small catalytic RNA.
    Müller S; Appel B; Krellenberg T; Petkovic S
    IUBMB Life; 2012 Jan; 64(1):36-47. PubMed ID: 22131309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ribozymes: the characteristics and properties of catalytic RNAs.
    Tanner NK
    FEMS Microbiol Rev; 1999 Jun; 23(3):257-75. PubMed ID: 10371033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.
    Kuwabara T; Warashina M; Tanabe T; Tani K; Asano S; Taira K
    Nucleic Acids Res; 1997 Aug; 25(15):3074-81. PubMed ID: 9224607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.